MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
BBOT — BridgeBio Oncology Therapeutics, Inc. Common Stock
NasdaqBridgeBio Oncology Therapeutics, Inc. Common Stock
$3.89
-0.05(-1.27%)
- O
- 3.97
- H
- 4.05
- L
- 3.88
- V
- 485.75K
⏱️ End-of-day dataAs of Oct 2, 2026
BBOT — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Fiscal Date | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Period | quarterly | quarterly | quarterly | quarterly | quarterly | quarterly |
| Year | 2,026.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,024.00 |
| Cash | 460,000.00 | N/A | $1.76M | 190,000.00 | 206,000.00 | N/A |
| Cash Equivalents | $52.20M | N/A | $40.70M | $31.33M | $26.01M | N/A |
| Cash And Cash Equivalents | $52.66M | $37.37M | $40.87M | $31.52M | $26.22M | $30.85M |
| Other Short Term Investments | $19.96M | $51.77M | $59.54M | $99.88M | $10.95M | $12.48M |
| Other Current Assets | $14.08M | $6.55M | $7.50M | 592,000.00 | $5.57M | $2.98M |
| Total Current Assets | $26.65M | $43.24M | $47.60M | $14.23M | $14.13M | $15.87M |
| Properties | $3.16M | $3.29M | $3.27M | $3.45M | $3.36M | N/A |
| Investments And Advances | $13.66M | N/A | N/A | N/A | N/A | N/A |
| Other Non Current Assets | $11.37M | $12.70M | $5.52M | $5.46M | $5.15M | $5.12M |
| Total Non Current Assets | $15.11M | $15.98M | $8.78M | $8.91M | $8.51M | $5.61M |
| Total Assets | $41.76M | $44.84M | $48.48M | $15.13M | $14.98M | $16.43M |
| Accounts Payable | $12.09M | $1.37M | $3.65M | $2.20M | $3.65M | $3.07M |
| Accrued Expenses | $27.90M | $26.86M | $26.38M | $21.66M | $14.18M | $9.10M |
| Short Term Debt | 538,000.00 | 522,000.00 | 506,000.00 | 320,000.00 | 6,000.00 | N/A |
| Pensions | $2.02M | $5.75M | $4.49M | $2.74M | $1.90M | $3.82M |
| Total Current Liabilities | $43.26M | $35.04M | $35.71M | $27.25M | $24.06M | $19.58M |
| Long Term Debt | $2.11M | $2.24M | $2.38M | $2.51M | $2.64M | N/A |
| Total Non Current Liabilities | $2.11M | $2.24M | $2.38M | $35.17M | $32.58M | $32.34M |
| Total Liabilities | $45.37M | $37.28M | $38.09M | $37.90M | $34.99M | $34.29M |
| Common Stock | 8,000.00 | 8,000.00 | 8,000.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | $-39.87M | $-35.66M | $-31.78M | $-27.30M | $-24.46M | $-22.25M |
| Other Shareholders Equity | -981,000.00 | 16,000.00 | 36,000.00 | 51,000.00 | 191,000.00 | 348,000.00 |
| Total Shareholders Equity | $37.23M | $41.11M | $44.67M | $-22.77M | $-20.00M | $-17.86M |
| Additional Paid In Capital | $77.19M | $76.76M | $76.44M | $45.23M | $44.35M | $43.54M |
| Prepaid Assets | N/A | N/A | N/A | $4.30M | N/A | N/A |
| Other Current Liabilities | N/A | N/A | N/A | N/A | $3.83M | $3.10M |